Conversely, others reported that NLRP3 inflammasome activation and the consequent release of IL-1β and IL-18 promoted tumor growth, proliferation, invasion, and metastasis in lung cancer, melanoma, breast cancer, and head and neck squamous cell carcinoma [129]. The gene discussed is NLRP3; the disease is breast cancer.